Stay updated on Nivolumab for Esophageal Cancer Clinical Trial
Sign up to get notified when there's something new on the Nivolumab for Esophageal Cancer Clinical Trial page.

Latest updates to the Nivolumab for Esophageal Cancer Clinical Trial page
- Check6 days agoNo Change Detected
- Check13 days agoChange DetectedThe Locations section shows new recruitment sites across multiple regions and removal of some prior sites. Revision updated to v3.3.3.SummaryDifference2%

- Check20 days agoNo Change Detected
- Check27 days agoNo Change Detected
- Check34 days agoChange DetectedRevision: v3.3.2 was added and Revision: v3.3.1 removed, indicating a site version update that does not affect study content or functionality. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check41 days agoChange DetectedPublication notes were clarified to indicate that publications are automatically filled from PubMed and may not be about the study. The revision information was updated from v3.2.0 to v3.3.1.SummaryDifference0.1%

- Check49 days agoChange DetectedAdded location 'Tainan, Taiwan, 704' and removed 'Tainan City, Taiwan, 704' from the study locations.SummaryDifference0.2%

- Check63 days agoChange DetectedThe page shows minor layout and timestamp updates. Core study data such as eligibility criteria, primary outcomes, and enrollment remain unchanged.SummaryDifference0.3%

- Check92 days agoChange Detected- Added a government-funding operating-status notice and link to NIH/cc information; page now shows Revision: v3.2.0. - Removed the resource topic: Carcinoma of esophagus (Genetic and Rare Diseases Information Center).SummaryDifference4%

Stay in the know with updates to Nivolumab for Esophageal Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Nivolumab for Esophageal Cancer Clinical Trial page.